Grifols (GIFLF) Interest Coverage Ratio Growth (3y) (2013 - 2024)
Powered by 
Analysis
Grifols (GIFLF) Interest Coverage Ratio Growth (3y) (2013 - 2024) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 203.97 Bn | 189.99 Bn | 7.24 Bn | 13.52% |
| 2 | Gilead Sciences | 178.74 Bn | 175.56 Bn | 6.22 Bn | -98.43% |
| 3 | Vertex Pharmaceuticals | 130.73 Bn | 122.88 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 80.42 Bn | 72.42 Bn | 3.93 Bn | 29.79% |
| 5 | Argenx Se | 60.40 Bn | 55.21 Bn | 1.37 Bn | 44.22% |
| 6 | Moderna | 57.65 Bn | 52.52 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.37 Bn | 30.07 Bn | 992.69 Mn | 33.30% |
| 8 | Biogen | 32.15 Bn | 30.86 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.58 Bn | 29.58 Bn | 1.16 Mn | - |
| 10 | Grifols | 7.54 Bn | 9.09 Bn | 3.33 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -906.83% |
| Dec 31, 2021 | -29.45% |
| Dec 31, 2020 | 12.80% |
| Dec 31, 2019 | 98.82% |
| Dec 31, 2018 | -27.04% |
| Jun 30, 2018 | -32.30% |
| Dec 31, 2017 | -31.79% |
| Jun 30, 2017 | 4.12% |
| Dec 31, 2016 | -60.76% |
| Sep 30, 2016 | 6.81% |
| Jun 30, 2016 | 5.74% |
| Dec 31, 2015 | 63.30% |
| Sep 30, 2015 | 19.55% |
| Jun 30, 2015 | 17.43% |
| Mar 31, 2015 | -56.76% |
| Dec 31, 2014 | 104.09% |
| Sep 30, 2014 | 33.18% |
| Jun 30, 2014 | 35.41% |
| Mar 31, 2014 | 31.08% |
| Dec 31, 2013 | 98.02% |